IP, Licensing and Collaborations Challenges and Opportunities in the Time of COVID-19

Overview

Please join Goodwin’s Life Sciences group for a weekly webinar series that aims to provide a multidisciplinary outlook on top-of-mind issues facing European life sciences companies in the era of COVID-19. 

This webinar series will be hosted and moderated by Goodwin Life Sciences Corporate partner Robert Puopolo. In each webinar, he will be joined by Goodwin colleagues and other market leaders to delve into the pertinent capital markets, regulatory, IP, licensing and cross-border M&A issues affecting European life sciences companies. 

This Session

Please join Goodwin’s Life Sciences Corporate partner Robert Puopolo in conversation with Goodwin’s Life Sciences IP partner Duncan Greenhalgh and Licensing & Collaboration partner Malcolm Bates along with Achilles Therapeutics Limited's Chief Business Officer, Beverly Carr, and VP of Intellectual Property, Liz Elmhirst, as they discuss market developments, challenges and opportunities in the currently unfolding COVID-19 pandemic from IP, licensing and collaborations perspectives. 

Request an Invitation